Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.
This report aims to provide a comprehensive presentation of the global market for Mesenchymal Stem Cells, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesenchymal Stem Cells. This report contains market size and forecasts of Mesenchymal Stem Cells in global, including the following market information:
Global Mesenchymal Stem Cells Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Mesenchymal Stem Cells market was valued at US$ 213.1 million in 2022 and is projected to reach US$ 286.3 million by 2029, at a CAGR of 4.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The top 3 manufacturters of Mesenchymal Stem Cells include ?Lonza, Thermo Fisher and Bio-Techne, with about 56% market shares.
North America region is the largest consumption of Mesenchymal Stem Cells, with a sales revenue market share nearly 41%. Europe is the second largest consumer of Mesenchymal Stem Cells, enjoying sales revenue market share about 31%.
We surveyed the Mesenchymal Stem Cells companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mesenchymal Stem Cells Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Mesenchymal Stem Cells Market Segment Percentages, by Type, 2022 (%)
Human MSC
Mouse MSC
Rat MSC
Others
Global Mesenchymal Stem Cells Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Mesenchymal Stem Cells Market Segment Percentages, by Application, 2022 (%)
Research Institute
Hospital
Others
Global Mesenchymal Stem Cells Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Mesenchymal Stem Cells Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mesenchymal Stem Cells revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Mesenchymal Stem Cells revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lonza
Thermo Fisher
Bio-Techne
ATCC
MilliporeSigma
PromoCell GmbH
Genlantis
Celprogen
Cell Applications
Cyagen Biosciences
Axol Bioscience
Outline of Major Chapters:
Chapter 1: Introduces the definition of Mesenchymal Stem Cells, market overview.
Chapter 2: Global Mesenchymal Stem Cells market size in revenue.
Chapter 3: Detailed analysis of Mesenchymal Stem Cells company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Mesenchymal Stem Cells in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Mesenchymal Stem Cells Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Mesenchymal Stem Cells Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Mesenchymal Stem Cells Overall Market Size
2.1 Global Mesenchymal Stem Cells Market Size: 2022 VS 2029
2.2 Global Mesenchymal Stem Cells Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Mesenchymal Stem Cells Players in Global Market
3.2 Top Global Mesenchymal Stem Cells Companies Ranked by Revenue
3.3 Global Mesenchymal Stem Cells Revenue by Companies
3.4 Top 3 and Top 5 Mesenchymal Stem Cells Companies in Global Market, by Revenue in 2022
3.5 Global Companies Mesenchymal Stem Cells Product Type
3.6 Tier 1, Tier 2 and Tier 3 Mesenchymal Stem Cells Players in Global Market
3.6.1 List of Global Tier 1 Mesenchymal Stem Cells Companies
3.6.2 List of Global Tier 2 and Tier 3 Mesenchymal Stem Cells Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Mesenchymal Stem Cells Market Size Markets, 2022 & 2029
4.1.2 Human MSC
4.1.3 Mouse MSC
4.1.4 Rat MSC
4.1.5 Others
4.2 By Type - Global Mesenchymal Stem Cells Revenue & Forecasts
4.2.1 By Type - Global Mesenchymal Stem Cells Revenue, 2018-2023
4.2.2 By Type - Global Mesenchymal Stem Cells Revenue, 2024-2029
4.2.3 By Type - Global Mesenchymal Stem Cells Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Mesenchymal Stem Cells Market Size, 2022 & 2029
5.1.2 Research Institute
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Mesenchymal Stem Cells Revenue & Forecasts
5.2.1 By Application - Global Mesenchymal Stem Cells Revenue, 2018-2023
5.2.2 By Application - Global Mesenchymal Stem Cells Revenue, 2024-2029
5.2.3 By Application - Global Mesenchymal Stem Cells Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Mesenchymal Stem Cells Market Size, 2022 & 2029
6.2 By Region - Global Mesenchymal Stem Cells Revenue & Forecasts
6.2.1 By Region - Global Mesenchymal Stem Cells Revenue, 2018-2023
6.2.2 By Region - Global Mesenchymal Stem Cells Revenue, 2024-2029
6.2.3 By Region - Global Mesenchymal Stem Cells Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Mesenchymal Stem Cells Revenue, 2018-2029
6.3.2 US Mesenchymal Stem Cells Market Size, 2018-2029
6.3.3 Canada Mesenchymal Stem Cells Market Size, 2018-2029
6.3.4 Mexico Mesenchymal Stem Cells Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Mesenchymal Stem Cells Revenue, 2018-2029
6.4.2 Germany Mesenchymal Stem Cells Market Size, 2018-2029
6.4.3 France Mesenchymal Stem Cells Market Size, 2018-2029
6.4.4 U.K. Mesenchymal Stem Cells Market Size, 2018-2029
6.4.5 Italy Mesenchymal Stem Cells Market Size, 2018-2029
6.4.6 Russia Mesenchymal Stem Cells Market Size, 2018-2029
6.4.7 Nordic Countries Mesenchymal Stem Cells Market Size, 2018-2029
6.4.8 Benelux Mesenchymal Stem Cells Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Mesenchymal Stem Cells Revenue, 2018-2029
6.5.2 China Mesenchymal Stem Cells Market Size, 2018-2029
6.5.3 Japan Mesenchymal Stem Cells Market Size, 2018-2029
6.5.4 South Korea Mesenchymal Stem Cells Market Size, 2018-2029
6.5.5 Southeast Asia Mesenchymal Stem Cells Market Size, 2018-2029
6.5.6 India Mesenchymal Stem Cells Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Mesenchymal Stem Cells Revenue, 2018-2029
6.6.2 Brazil Mesenchymal Stem Cells Market Size, 2018-2029
6.6.3 Argentina Mesenchymal Stem Cells Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Mesenchymal Stem Cells Revenue, 2018-2029
6.7.2 Turkey Mesenchymal Stem Cells Market Size, 2018-2029
6.7.3 Israel Mesenchymal Stem Cells Market Size, 2018-2029
6.7.4 Saudi Arabia Mesenchymal Stem Cells Market Size, 2018-2029
6.7.5 UAE Mesenchymal Stem Cells Market Size, 2018-2029
7 Mesenchymal Stem Cells Companies Profiles
7.1 Lonza
7.1.1 Lonza Company Summary
7.1.2 Lonza Business Overview
7.1.3 Lonza Mesenchymal Stem Cells Major Product Offerings
7.1.4 Lonza Mesenchymal Stem Cells Revenue in Global Market (2018-2023)
7.1.5 Lonza Key News & Latest Developments
7.2 Thermo Fisher
7.2.1 Thermo Fisher Company Summary
7.2.2 Thermo Fisher Business Overview
7.2.3 Thermo Fisher Mesenchymal Stem Cells Major Product Offerings
7.2.4 Thermo Fisher Mesenchymal Stem Cells Revenue in Global Market (2018-2023)
7.2.5 Thermo Fisher Key News & Latest Developments
7.3 Bio-Techne
7.3.1 Bio-Techne Company Summary
7.3.2 Bio-Techne Business Overview
7.3.3 Bio-Techne Mesenchymal Stem Cells Major Product Offerings
7.3.4 Bio-Techne Mesenchymal Stem Cells Revenue in Global Market (2018-2023)
7.3.5 Bio-Techne Key News & Latest Developments
7.4 ATCC
7.4.1 ATCC Company Summary
7.4.2 ATCC Business Overview
7.4.3 ATCC Mesenchymal Stem Cells Major Product Offerings
7.4.4 ATCC Mesenchymal Stem Cells Revenue in Global Market (2018-2023)
7.4.5 ATCC Key News & Latest Developments
7.5 MilliporeSigma
7.5.1 MilliporeSigma Company Summary
7.5.2 MilliporeSigma Business Overview
7.5.3 MilliporeSigma Mesenchymal Stem Cells Major Product Offerings
7.5.4 MilliporeSigma Mesenchymal Stem Cells Revenue in Global Market (2018-2023)
7.5.5 MilliporeSigma Key News & Latest Developments
7.6 PromoCell GmbH
7.6.1 PromoCell GmbH Company Summary
7.6.2 PromoCell GmbH Business Overview
7.6.3 PromoCell GmbH Mesenchymal Stem Cells Major Product Offerings
7.6.4 PromoCell GmbH Mesenchymal Stem Cells Revenue in Global Market (2018-2023)
7.6.5 PromoCell GmbH Key News & Latest Developments
7.7 Genlantis
7.7.1 Genlantis Company Summary
7.7.2 Genlantis Business Overview
7.7.3 Genlantis Mesenchymal Stem Cells Major Product Offerings
7.7.4 Genlantis Mesenchymal Stem Cells Revenue in Global Market (2018-2023)
7.7.5 Genlantis Key News & Latest Developments
7.8 Celprogen
7.8.1 Celprogen Company Summary
7.8.2 Celprogen Business Overview
7.8.3 Celprogen Mesenchymal Stem Cells Major Product Offerings
7.8.4 Celprogen Mesenchymal Stem Cells Revenue in Global Market (2018-2023)
7.8.5 Celprogen Key News & Latest Developments
7.9 Cell Applications
7.9.1 Cell Applications Company Summary
7.9.2 Cell Applications Business Overview
7.9.3 Cell Applications Mesenchymal Stem Cells Major Product Offerings
7.9.4 Cell Applications Mesenchymal Stem Cells Revenue in Global Market (2018-2023)
7.9.5 Cell Applications Key News & Latest Developments
7.10 Cyagen Biosciences
7.10.1 Cyagen Biosciences Company Summary
7.10.2 Cyagen Biosciences Business Overview
7.10.3 Cyagen Biosciences Mesenchymal Stem Cells Major Product Offerings
7.10.4 Cyagen Biosciences Mesenchymal Stem Cells Revenue in Global Market (2018-2023)
7.10.5 Cyagen Biosciences Key News & Latest Developments
7.11 Axol Bioscience
7.11.1 Axol Bioscience Company Summary
7.11.2 Axol Bioscience Business Overview
7.11.3 Axol Bioscience Mesenchymal Stem Cells Major Product Offerings
7.11.4 Axol Bioscience Mesenchymal Stem Cells Revenue in Global Market (2018-2023)
7.11.5 Axol Bioscience Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Mesenchymal Stem Cells Market Opportunities & Trends in Global Market
Table 2. Mesenchymal Stem Cells Market Drivers in Global Market
Table 3. Mesenchymal Stem Cells Market Restraints in Global Market
Table 4. Key Players of Mesenchymal Stem Cells in Global Market
Table 5. Top Mesenchymal Stem Cells Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Mesenchymal Stem Cells Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Mesenchymal Stem Cells Revenue Share by Companies, 2018-2023
Table 8. Global Companies Mesenchymal Stem Cells Product Type
Table 9. List of Global Tier 1 Mesenchymal Stem Cells Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Mesenchymal Stem Cells Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Mesenchymal Stem Cells Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Mesenchymal Stem Cells Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Mesenchymal Stem Cells Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Mesenchymal Stem Cells Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Mesenchymal Stem Cells Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Mesenchymal Stem Cells Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Mesenchymal Stem Cells Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Mesenchymal Stem Cells Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Mesenchymal Stem Cells Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Mesenchymal Stem Cells Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Mesenchymal Stem Cells Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Mesenchymal Stem Cells Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Mesenchymal Stem Cells Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Mesenchymal Stem Cells Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Mesenchymal Stem Cells Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Mesenchymal Stem Cells Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Mesenchymal Stem Cells Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Mesenchymal Stem Cells Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Mesenchymal Stem Cells Revenue, (US$, Mn), 2024-2029
Table 30. Lonza Company Summary
Table 31. Lonza Mesenchymal Stem Cells Product Offerings
Table 32. Lonza Mesenchymal Stem Cells Revenue (US$, Mn) & (2018-2023)
Table 33. Lonza Key News & Latest Developments
Table 34. Thermo Fisher Company Summary
Table 35. Thermo Fisher Mesenchymal Stem Cells Product Offerings
Table 36. Thermo Fisher Mesenchymal Stem Cells Revenue (US$, Mn) & (2018-2023)
Table 37. Thermo Fisher Key News & Latest Developments
Table 38. Bio-Techne Company Summary
Table 39. Bio-Techne Mesenchymal Stem Cells Product Offerings
Table 40. Bio-Techne Mesenchymal Stem Cells Revenue (US$, Mn) & (2018-2023)
Table 41. Bio-Techne Key News & Latest Developments
Table 42. ATCC Company Summary
Table 43. ATCC Mesenchymal Stem Cells Product Offerings
Table 44. ATCC Mesenchymal Stem Cells Revenue (US$, Mn) & (2018-2023)
Table 45. ATCC Key News & Latest Developments
Table 46. MilliporeSigma Company Summary
Table 47. MilliporeSigma Mesenchymal Stem Cells Product Offerings
Table 48. MilliporeSigma Mesenchymal Stem Cells Revenue (US$, Mn) & (2018-2023)
Table 49. MilliporeSigma Key News & Latest Developments
Table 50. PromoCell GmbH Company Summary
Table 51. PromoCell GmbH Mesenchymal Stem Cells Product Offerings
Table 52. PromoCell GmbH Mesenchymal Stem Cells Revenue (US$, Mn) & (2018-2023)
Table 53. PromoCell GmbH Key News & Latest Developments
Table 54. Genlantis Company Summary
Table 55. Genlantis Mesenchymal Stem Cells Product Offerings
Table 56. Genlantis Mesenchymal Stem Cells Revenue (US$, Mn) & (2018-2023)
Table 57. Genlantis Key News & Latest Developments
Table 58. Celprogen Company Summary
Table 59. Celprogen Mesenchymal Stem Cells Product Offerings
Table 60. Celprogen Mesenchymal Stem Cells Revenue (US$, Mn) & (2018-2023)
Table 61. Celprogen Key News & Latest Developments
Table 62. Cell Applications Company Summary
Table 63. Cell Applications Mesenchymal Stem Cells Product Offerings
Table 64. Cell Applications Mesenchymal Stem Cells Revenue (US$, Mn) & (2018-2023)
Table 65. Cell Applications Key News & Latest Developments
Table 66. Cyagen Biosciences Company Summary
Table 67. Cyagen Biosciences Mesenchymal Stem Cells Product Offerings
Table 68. Cyagen Biosciences Mesenchymal Stem Cells Revenue (US$, Mn) & (2018-2023)
Table 69. Cyagen Biosciences Key News & Latest Developments
Table 70. Axol Bioscience Company Summary
Table 71. Axol Bioscience Mesenchymal Stem Cells Product Offerings
Table 72. Axol Bioscience Mesenchymal Stem Cells Revenue (US$, Mn) & (2018-2023)
Table 73. Axol Bioscience Key News & Latest Developments
List of Figures
Figure 1. Mesenchymal Stem Cells Segment by Type in 2022
Figure 2. Mesenchymal Stem Cells Segment by Application in 2022
Figure 3. Global Mesenchymal Stem Cells Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Mesenchymal Stem Cells Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Mesenchymal Stem Cells Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Mesenchymal Stem Cells Revenue in 2022
Figure 8. By Type - Global Mesenchymal Stem Cells Revenue Market Share, 2018-2029
Figure 9. By Application - Global Mesenchymal Stem Cells Revenue Market Share, 2018-2029
Figure 10. By Type - Global Mesenchymal Stem Cells Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Mesenchymal Stem Cells Revenue Market Share, 2018-2029
Figure 12. By Application - Global Mesenchymal Stem Cells Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Mesenchymal Stem Cells Revenue Market Share, 2018-2029
Figure 14. By Region - Global Mesenchymal Stem Cells Revenue Market Share, 2018-2029
Figure 15. By Country - North America Mesenchymal Stem Cells Revenue Market Share, 2018-2029
Figure 16. US Mesenchymal Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Mesenchymal Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Mesenchymal Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Mesenchymal Stem Cells Revenue Market Share, 2018-2029
Figure 20. Germany Mesenchymal Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 21. France Mesenchymal Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Mesenchymal Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Mesenchymal Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Mesenchymal Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Mesenchymal Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Mesenchymal Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Mesenchymal Stem Cells Revenue Market Share, 2018-2029
Figure 28. China Mesenchymal Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Mesenchymal Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Mesenchymal Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Mesenchymal Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 32. India Mesenchymal Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Mesenchymal Stem Cells Revenue Market Share, 2018-2029
Figure 34. Brazil Mesenchymal Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Mesenchymal Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Mesenchymal Stem Cells Revenue Market Share, 2018-2029
Figure 37. Turkey Mesenchymal Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Mesenchymal Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Mesenchymal Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Mesenchymal Stem Cells Revenue, (US$, Mn), 2018-2029
Figure 41. Lonza Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Thermo Fisher Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Bio-Techne Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. ATCC Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. MilliporeSigma Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. PromoCell GmbH Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Genlantis Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Celprogen Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Cell Applications Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Cyagen Biosciences Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Axol Bioscience Mesenchymal Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
